Solid Biosciences Inc.
SLDB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001707502
No open-market purchases or sales by Solid Biosciences Inc. insiders were filed in the last 90 days; 157 institutions reported holding it in 13F filings for Q2 2026, worth $1.14B in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Solid Biosciences Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 35 | 39 | +4 |
| Shares | 15.3M | 15.8M | +464.7K (+3.0%) |
| Value | $85.6M | $74.8M | −$10.9M (−12.7%) |
New holders (10)
Institutions that held Solid Biosciences Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pura Vida Investments, LLC | 224,902 | $1.07M | 0.11% |
| Great Point Partners LLC | 210,405 | $997.3K | 0.20% |
| Susquehanna International Group, LLP | 18,690 | $88.6K | 0.00% |
| CIBC Asset Management Inc | 12,083 | $57.3K | 0.00% |
| Citadel Advisors LLC | 11,756 | $55.7K | 0.00% |
| Northern Trust Corp | 11,062 | $52.4K | 0.00% |
| Charles Schwab Investment Management Inc | 10,000 | $47.4K | 0.00% |
| Lazard Asset Management LLC | 2,089 | $9.00K | 0.00% |
| FMR LLC | 300 | $1.42K | 0.00% |
| Baker Avenue Asset Management, LP | 66 | $313 | 0.00% |
Sold out (6)
Institutions that held Solid Biosciences Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| K2 Principal Fund, L.P. | 342,271 | $1.84M |
| Millennium Management LLC | 12,846 | $69.0K |
| Old Well Partners, LLC | 10,800 | $58.1K |
| Acadian Asset Management LLC | 9,507 | $50.0K |
| Belpointe Asset Management LLC | 1,367 | $7.35K |
| Investors Research Corp | 13 | $70 |